SPAC Overview
Timeline Progress
About
Research Alliance Corporation III is a blank-check company formed to effect a business combination with an unidentified business. Its focus is healthcare and healthcare-related industries, particularly drug development and commercialization, diagnostics, and healthcare technology and services.
Investment Focus
Healthcare, Biopharmaceuticals
Geographic Focus
United States
The terms and the filing trail behind Research Alliance Corporation III
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
The team is affiliated with RA Capital Management, a life-sciences-focused investment firm. CEO and director Matthew Hammond and Chief Business Officer and Chief Operating Officer Henry Stusnick are members of its investment team; the director nominees bring biotechnology, life-sciences, finance, and operating experience. The team has prior SPAC experience with Research Alliance Corp. I, which combined with POINT Biopharma.